Fiche centre
Investigational Site Number : 2680005
Tbilisi — Georgia
Essais liés2clinical trials
VilleTbilisilocalisation
PaysGeorgialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04458051
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SAR441344 IV | Lupus | Phase 2 | NCT05039840 | APATURA — Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING |
| Tolebrutinib | SEP | Phase 3 | NCT04458051 | Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) | COMPLETED |